World

Avian influenza outbreak not threat to Australia's egg supply: agriculture minister

Jun 11, 2024

Canberra [Australia], June 11: Australia is not at risk of an egg shortage despite an outbreak of avian influenza, the agriculture minister has said.
Murray Watt on Tuesday said there is no reason for Australians to be worried about a national shortage of eggs after the highly pathogenic H7N3 strain of bird flu was detected at five farms in the state of Victoria.
He told state media Australian Broadcasting Corporation (ABC) television that 1 million hens have been euthanized or otherwise affected by the outbreak, representing approximately four percent of Australia's national flock of egg-laying chickens.
In response, Coles -- one of Australia's two largest supermarket chains -- has limited the number of eggs customers can buy to two cartons in all stores across the nation except in Western Australia (WA).
However, Watt said there was no cause for alarm about the supply of eggs.
"Every day Australia produces 18 million eggs and there's no risk to that supply stopping any time soon," he said.
Watt said that the outbreak would have affected more farms if not for a quick quarantine response from the Victorian government but said he could not guarantee that it has been entirely contained.
"I can't rule out that it'd be spreading further, but obviously every effort is being put in by the Victorian government, backed by ourselves," he said.
He said the strain of avian influenza that has been detected in Victoria is not the deadly strain that has been detected elsewhere in the world and said Australians can continue to eat eggs safely.
Source: Xinhua

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025